Prehypertension and chronic kidney disease: the ox or the plow?

John P Middleton1, Steven D Crowley

  • 1Division of Nephrology, Duke University, Durham, North Carolina 27705, USA. j.p.middleton@duke.edu

Kidney International
|January 14, 2012
PubMed

Insights

Prehypertension, a blood pressure stage, is linked to increased risks of cardiovascular and cerebrovascular diseases. New research indicates it

Area of Science:

  • Nephrology
  • Cardiology
  • Public Health

Background:

  • Clinical guidelines previously defined prehypertension as systolic blood pressure (SBP) of 120–139 mm Hg or diastolic blood pressure (DBP) of 80–89 mm Hg.
  • This classification stemmed from evidence associating these blood pressure ranges with elevated cardiovascular and cerebrovascular risks compared to normal levels (<120/80 mm Hg).

Purpose of the Study:

  • To investigate the association between prehypertension and the risk of developing chronic kidney disease (CKD).

Main Methods:

  • Observational study analyzing data from Yano et al.
  • Included individuals classified with prehypertension based on established blood pressure thresholds.

Main Results:

  • Prehypertension is identified as a significant risk factor for the development of chronic kidney disease.
  • This finding extends the known risks associated with prehypertension beyond cardiovascular and cerebrovascular conditions.

Conclusions:

  • Prehypertension poses a considerable risk for CKD development.
  • Clinical awareness and management strategies for prehypertension should consider its impact on kidney health.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...